Clinical Trials Browser

Interventional × NSCLC × Drug Therapy × Clear all

NCT06738160 2026-02-06

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

Phase 2 Recruiting

NSCLC

NCT07247227 2025-11-25

Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC

Phase NA Recruiting

NSCLC

NCT07134413 2025-08-21

QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC

Phase 2 Not yet recruiting

NSCLC

NCT06479759 2024-06-28

ACCLAIM

Phase 2 Recruiting

NSCLC

NCT05286957 2023-03-17

Seagull

Phase 2 Recruiting

NSCLC

NCT05209256 2022-01-26

Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC

Phase 2/3 Unknown

NSCLC

NCT03986528 2021-02-23

Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Unknown

NSCLC